Cardiac M2 muscarinic cholinoceptor activation by human chagasic autoantibodies: Association with bradycardia

Heart

Volumn 82, Issue 3, 1999, Pages 273-278

  Goin, J C ^a   Borda, E S ^a   Auger, S ^a   Storino, R ^a   Sterin Borda, L ^a  

^a School of Medicine and Dentistry   (Argentina)

Author keywords

Autoantibodies; Bradycardia; Chagasic cardiomyopathy; Heart rate

Indexed keywords

ATROPINE; AUTOANTIBODY; CARBACHOL; CYCLIC AMP; IMMUNOGLOBULIN G; MUSCARINIC M2 RECEPTOR; OTENZEPAD;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSAUTONOMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRYPANOSOMA CRUZI;

EID: 0032871495     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.3.273     Document Type: Article

References (27)

1. 1 Koberle F. Pathology and pathological anatomy of Chagas' disease. Bol OPS 1974;140:38-53.
2. 2 Cossio PM, Diez C, Szarfman A, et al. Chagasic cardiopathy: demonstration of serum gamma globulin factor which reacts with endocardium and vascular tissue. Circulation 1974;49:13-21.
3. 3 Santos Buch CA, Texeira AR. The immunology of experimental Chagas' disease rejection of allogenic heart cells in vitro. J Exp Med 1974;140:38-53.
4. 4 Wood JN, Hudson L, Jessell TM, et al. A monoclonal antibody defining antigen determinants on subpopulations of mammalian neurons and T cruzi parasites. Nature 1982;296:34-38.
5. 5 McCormick TS, Rowland EC. T cruzi cross-reactivity antiheart autoantibodies produced during infection in mice. Exp Parasitol 1989,69:393-401.
6. 6 Sterin-Borda L, Gorelik G, Genaro AM, et al. Human chagasic IgG interacting with lymphocyte neurotransmitter receptors trigger intracellular signal transduction. FASEB J 1990;4:161-7.
7. 7 Goin JC, Perez Leiros C, Borda ES, et al. Human chagasic IgG and muscarinic cholinergic receptor interaction: pharmacological and molecular evidences. Mol Neuropharmacol 1994,3:189-96.
8. 8 Sterin-Borda L, Gorelik G, Borda ES. Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals. Clin Immunol Immunopathol 1991;61: 389-97.
9. 9 Cremaschi G, Zwirner NW, Gorelik G, et al. Modulation of cardiac physiology by an anti-trypanosoma cruzi monoclonal antibody after interaction with myocardium. FASEB J 1995;9:1482-8.
10. 10 Goin JC, Borda ES, Perez Leiros C, et al. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Syst 1994;47:45-52.
11. 2 adrenoceptors in Chagas' disease. Clin Exp Immunol 1988;74:349-54.
12. 12 Borda E, Pascual J, Cossio PR, et al. A circulating IgG in Chagas' disease which binds to beta adrenoceptor of myocardium and modulates its activity. Clin Exp Immunol 1984;54:679-86.
13. 13 Borda E, Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Im J Cardiol 1996;54:149-56.
14. 14 Koberle F. Pathogenesis of Chagas' disease. In: Ciba Foundation Symposium. Amsterdam: Associated Scientific Publications, 1974:137-58.
15. 15 Iosa D, Dequatro V, De Ping L, et al. Pathogenesis of cardiac neuromyopathy in Chagas' disease and the role of the autonomic nervous system. J Auton Nerv Syst 1990;30:83-8.
16. 16 Sterin-Borda L, Borda ES. Participation of the autonomic nervous system in the pathogenesis of Chagas' disease. Acta Physiol Pharmacol Ther Latinoam 1994;44: 109-23.
17. 17 Goin JC, Perez Leiros C, Borda ES, et al. Modulation of cholinergic-mediated cellular transmembrane signals by the interaction of human chagasic IgG with cardiac muscarinic receptors. Neuroimmunomodulation 1994;1: 284-91.
18. 18 Sterin-Borda L, Perez Leiros C, Goin JC, et al. Participation of nitric oxide signaling system in the cardiac muscarinic cholinergic effect of human chagasic IgG, J Mol Cell Cardiol 1977;29:1851-65.
19. 19 Sterin-Borda L, Cremaschi G, Genaro AM, et al. Involvement of nitric oxide synthase and protein kinase C activation on chagasic antibodies action upon cardiac contractility. Mol Cell Biochem 1996;160;161: 75-82.
20. 20 Goin JC, Perez Leiros C, Borda ES, et al. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 1997; 10:77-83.
21. 21 Palmero HA, Caeiro A. Epidemiologia de la hipertension en Cordoba, Argentina. La presion arterial en funcion de la edad y el sexo. Medicina (Buenos Aires) 1979;31: 393-8.
22. 22 Storino R, Milei J. In: Miocardiopatía Chagásica Crónica. Buenos Aires: Club de Estudio, 1986:121-75.
23. 23 Brown B, Albano J, Elkins R, et al. Simple and selective saturation assay method for the measurement of adenosine 3′,5-cyclic monophosphate. Biochem J 1971; 121:561-2.
24. 24 Perez Leiros C, Sterin-Borda L, Borda E, et al. Desensitization and sequestration of human M2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J Biol Chem 1997;272:12989-93.
25. 25 Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.
26. 26 Bacman S, Sterin-Borda L, Camusso JJ, et al. Circulating antibodies against neurotransmitter receptors activities in children with congenital heart block and their mothers. FASEB J 1994;8:1170-6.
27. 27 Borda ES, Camusso JJ, Perez Leiros C, et al. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome. Mol Cell Biochem 1996;164/165:335-341.